Muka Metal S.A. has been acquired by Stryker Corporation
The private shareholders and owners of Muka Metal, A.S. have sold the company to Stryker Corporation. Financial details have not been disclosed.
Since launching its first hospital bed in 2002, Muka Metal has established itself as a leading manufacturer and marketer of hospital beds, stretchers and related patient room furniture and accessories. In 2014, Muka Metal finished the construction of a state-of-the-art facility located in a free trade zone within Kayseri, Turkey.
Headquartered in Kalamazoo, Michigan,USA, Stryker Corporation is one of the world's leading medical technology companies and offers a diverse array of innovative products and services in orthopedics, medical and surgical, and neurotechnology and spine, which help improve patient and hospital outcomes. This transaction will expand Stryker’s presence in Turkey as well as in Latin America, while also providing a product portfolio that complements and enhances Stryker's current portfolio.
"The acquisition of Muka Metal aligns with our strategy to expand our global presence through existing channels with an established and trusted brand," said Timothy J. Scannell, Stryker Group President, MedSurg and Neurotechnology. "This acquisition will bolster Stryker Medical's bed and stretcher offerings, and is a compelling opportunity to drive growth in Turkey and other regions around the world."
Oaklins' team in Turkey acted as the exclusive financial advisor to the seller in this transaction.
Talk to the deal team
Related deals
Instituto Sanitas and Chemopharma have been acquired by Laboratorios Saval
Instituto Sanitas and Chemopharma, leading pharmaceutical laboratories in Chile, have been acquired by Laboratorios Saval S.A., a prominent pharmaceutical company based in Chile with a regional presence across Latin America. The transaction strengthens Laboratorios Saval’s growth strategy and supports its expansion in the affordable medicines segment.
Learn moreRare Patient Voice has been acquired by Konovo
Rare Patient Voice has been acquired by Konovo, a technology-first healthcare intelligence company backed by Fraser Healthcare Partners.
Learn moreLindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland
LabPoint Medical Laboratories AG has been acquired by Affidea Switzerland AG. Through the transaction, Lindenhofgruppe AG gains a strong strategic partner to support the further development of LabPoint and will remain a shareholder with a reduced stake, continuing as a key customer of the company. It lays the foundation for LabPoint’s sustainable development under a new anchor shareholder, with the aim of further strengthening and selectively expanding its position in laboratory diagnostics.
Learn more